跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,920 条关于
“PD-L1 protein”
全部
19,920
临床试验
10,402
药物
1,960
机构
60
资讯
7,498
11个月前
Kazia Therapeutics Secures First-in-Class PD-L1 Protein Degrader Through QIMR Berghofer Partnership
去年
Summit Therapeutics' Ivonescimab Shows Promise Against Merck's Keytruda in Lung Cancer Trial
去年
FDA Approves Checkpoint Therapeutics' Unloxcyt (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma
2年前
FDA Approves New Endometrial Cancer Therapies, Expanding Treatment Options
2年前
AstraZeneca's Imfinzi Shows Positive Results in Bladder Cancer Trial
去年
Merck's Keytruda Faces New Competition in Cancer Treatment Arena
2年前
Perioperative Nivolumab Reduces Recurrence and Death in Resectable NSCLC
2年前
Perioperative Durvalumab Shows Significant Benefit in Muscle-Invasive Bladder Cancer
2年前
Imfinzi and Imjudo Combo Shows Unprecedented Survival in Liver Cancer
6年前
Immunotherapy Timing Crucial for Advanced Bladder Cancer Treatment
第 1 页,共 750 页
上一页
下一页